GSK618334
Sponsors
GlaxoSmithKline
Conditions
Substance Dependence
Phase 1
To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334
CompletedNCT00513279
Start: 2007-06-28End: 2007-10-04Updated: 2017-09-15
An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand
CompletedNCT00814957
Start: 2008-12-08End: 2009-06-11Updated: 2017-07-07